Melbourne, Australia-based animal therapeutics developer Nexvet Biopharma scored $31.5 million in a funding round from investors and shareholders to expand its product portfolio and clinical program for pets' health.
Breaking News
Melbourne, Australia-based animal therapeutics developer Nexvet Biopharma scored $31.5 million in a funding round from investors and shareholders to expand its product portfolio and clinical program for pets' health.
